Clinical Pharmacology. Proceedings of the 7th International Congress of Pharmacology, Paris 1978

Content: 
ADVANCES IN PHARMACOLOGY AND THERAPEUTICS, Page ii
Front Matter, Page iii
Copyright, Page iv
Introduction, Pages ix-x, Jacques R BOISSIER
Genetic and Environmental Factors Responsible for Interindividual Variations in Drug Response, Pages 3-12, Elliot S. Vesell
Interindividual Differences in Plasma Concentrations and Effect of the Adrenergic Beta-receptor Blocking Drug Alprenolol and its Metabolite 4-hydroxy-alprenolol in Man, Pages 13-22, Christer von Bahr, Karl-Olof Borg, Per Collste
Interindividual Differences in Drug Response. Studies with Indomethacin and Oral Contraceptive Steroids, Pages 23-30, M.L'E. Orme, N. Baber, D.J. Back, A.M. Breckenridge, L. Halliday, T. Littler
Pharmacogenetic Investigation of Amobarbital Disposition, Pages 31-40, W. Kalow, L. Endrenyi, T. Inaba, D. Kadar, B. Tang
New Methods and Models for the Isoniazid Acetylation Polymorphism, Pages 41-50, W. Weber, R. Tannen, C. McQueen, I. Glowinski
Polymorphic Drug Acetylation and Systemic Lupus Erythematosus, Pages 51-56, Marcus M. Reidenberg, Dennis E. Drayer, William C. Robbins
Problems of Drugs Administration in the Neonatal Period, Pages 57-66, Paolo Lucio Morselli
The Effect of Disease on the Response to Drugs, Pages 67-76, Roland Gugler
Drug Utilization - Geographical Differences and Clinical Implications: INTRODUCTORY REMARKS, Pages 79-82, P.K.M. Lunde, M. Levy
Methodologies and Approaches in Drug Utilisation Studies, Pages 83-92, Ludvík Štika
Drug Prescribing in Hospitals: An International Comparison, Pages 93-99, D.H. Lawson, H. Jick
Drug Utilization Strategies within Regional Programs on Drug Control and Evaluation, Pages 101-112, G. Tognoni, C. Bellantuono, F. Colombo, M.L. Farina, L. Ferrario, M.G. Franzosi, M. Mancini, M. Mandelli
Drug Utilization — Geographical Differences and Clinical Implications — Psychotropic Drugs, Pages 113-121, Barbro Westerholm, F. Kristensen, H.U. Schaffalitzky de Muckadell, J. Idänpään-Heikkilä, T. Lahti, A. Grimsson, O. Olaffson, C. McMeekin, P.K.M. Lunde, K. Oydvin
Drug Utilization — Geographical Differences and Clinical Implications — Antidiabetic Drugs, Pages 123-132, Ulf Bergman
Antihypertensive Drugs, Pages 133-141, Ingebjorg Baksaas
Digoxin - Compliance as a Factor in Drug Utilisation, Pages 143-151, Denis G. McDevitt, G. Dennis Johnston
Drug Utilization, the Role and Effect of Clinical Pharmacology, Pages 153-159, Micha Levy
Controls of Drug Utilization: National and International Implications, Pages 161-168, William M. Wardell
Drug Utilization — Geographical Differences and Clinical Implications: CONCLUDING REMARKS, Pages 169-170, M. Levy, P.K.M. Lunde
Summary, Page 172
Surveillance of Drugs in Therapeutic Use, Pages 173-174, Antal Káldor
Registered Release: a Method for Detecting Adverse Drug Reactions, Pages 175-178, C.T. Dollery
Surveillance of Drugs in Therapeutic Use in Developing Countries, Pages 179-187, U.K. Sheth
Methods of “Audit” in Drug Use, Pages 189-195, James Crooks
The Value and Limitations of Patient Registers in Drug Surveillance, Pages 197-202, Barbro Westerholm
Experiences of the Boston Collaborative Drug Surveillance Program, Pages 203-207, Hershel Jick
Relevance of “in Vitro” Electrophysiologic Effects of Antiarrhythmic Drugs to their Efficacy under “in vivo” Conditions, Pages 211-219, László Szekeres, Julius Gy. Papp
Arrhythmias Caused by Cardiac Glycosides, Pages 221-230,235-236, Mario Vassalle
From Experiment to Therapeutic Application in the Field of Antiarrhythmics, Pages 237-244, N.V. Kaverina
Clinical use of Antiarrhythmic Drugs. The Relevance of Experimental Data, Pages 245-248, Philippe Coumel
New Antiarrhythmics. The need for bridging the gap between the pharmacologist and the clinician, Pages 249-256, H.J.J. Wellens
Theoretical Considerations Concerning Drug Treatment of Dysrhythmias due to Coronary Insufficiency, Pages 257-275, László Szekeres
Index, Pages 277-280